|
|
|
Volumn 28, Issue 2, 1996, Pages 970-973
|
|
Pharmacokinetics of rapamycin
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOSPORIN A;
CYCLOSPORIN G;
CYTOCHROME P450;
DRUG VEHICLE;
HIGH DENSITY LIPOPROTEIN;
LOW DENSITY LIPOPROTEIN;
N,N DIMETHYLACETAMIDE;
PREDNISONE;
RAPAMYCIN;
TACROLIMUS;
VERY LOW DENSITY LIPOPROTEIN;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG DISTRIBUTION;
DRUG EFFICACY;
DRUG ERYTHROCYTE LEVEL;
DRUG HALF LIFE;
DRUG POTENCY;
DRUG PROTEIN BINDING;
GRAFT SURVIVAL;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INTRAVENOUS DRUG ADMINISTRATION;
KIDNEY TRANSPLANTATION;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
SIDE EFFECT;
SUBCUTANEOUS DRUG ADMINISTRATION;
ANIMALS;
CLINICAL TRIALS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
POLYENES;
SIROLIMUS;
TRANSPLANTATION IMMUNOLOGY;
|
|
EID: 0029929678
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (54)
|
|
References (0)
|
